These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22798444)

  • 1. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP.
    Bayraktar S; Eileen B; Shariatmadar S; Lian E
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
    Al-Husban N; Al-Kuran O
    J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
    Ojeda-Uribe M; Brunot A; Issler M
    Rev Med Chil; 2005 Nov; 133(11):1349-54. PubMed ID: 16446859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)].
    Illner N; Wolf G
    Dtsch Med Wochenschr; 2010 May; 135(3):71-4. PubMed ID: 20077379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases.
    Evans MW; Vaughan LB; Giffi VS; Zimrin AB; Hess JR
    AIDS Patient Care STDS; 2010 Jun; 24(6):349-52. PubMed ID: 20515417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
    Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
    Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report.
    Ge H; Shi Z; Zheng Z; Zhu Q; Hong L; Zhang Y; Shen J; Deng S
    J Int Med Res; 2022 Mar; 50(3):3000605221085127. PubMed ID: 35352601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Narayanan P; Jayaraman A; Rustagi RS; Mahadevan S; Parameswaran S
    Int J Hematol; 2012 Jul; 96(1):122-4. PubMed ID: 22552883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
    Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
    Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.
    Ozdogu H; Boga C; Kizilkilic E; Yeral M; Kozanoglu I; Karatas M
    J Thromb Thrombolysis; 2007 Apr; 23(2):147-50. PubMed ID: 17221322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports.
    Watanabe A; Shiseki M; Oishi M; Kobayashi M; Oshima S; Osanai S; Ryuzaki M; Izuka Y; Tanaka N; Ishiyama M; Shinohara A; Kazama H; Hagiwara S; Yoshinaga K; Tanaka J
    Intern Med; 2021 Sep; 60(17):2859-2862. PubMed ID: 33775998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rituximab for treatment of immune thrombocytopenia and thrombotic thrombocytopenic purpura].
    Miyakawa Y
    Rinsho Ketsueki; 2019; 60(5):480-487. PubMed ID: 31168017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM; Uener J; Hallek M; Scheid C
    Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting B cells in severe thrombotic thrombocytopenic purpura--a road to cure?
    Kyttaris VC
    Crit Care Med; 2012 Jan; 40(1):317-8. PubMed ID: 22179358
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab.
    Alkindi S; Khan S; Riyami D; Farooqi M; Pathare A
    Platelets; 2010; 21(7):575-7. PubMed ID: 20624006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
    Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X
    Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism.
    Okumura T; Hashimoto K; Aomura D; Kurasawa Y; Hara Y; Fujii K; Masuda T; Sonoda K; Yamaguchi A; Ogawa Y; Kamijo Y
    Intern Med; 2020 Mar; 59(5):715-719. PubMed ID: 31708547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide.
    Stein GY; Zeidman A; Fradin Z; Varon M; Cohen A; Mittelman M
    Int J Hematol; 2004 Jul; 80(1):94-6. PubMed ID: 15293577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics; 2. Rituximab for ITP and TTP].
    Miyakawa Y
    Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1654-9. PubMed ID: 25154261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.